Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
PremiumPress ReleasesAnnovis Bio Reports Second Quarter Financial Results and Provides Business Update
1M ago
Annovis Bio reports Q2 EPS (44c), consensus (63c)
Premium
The Fly
Annovis Bio reports Q2 EPS (44c), consensus (63c)
1M ago
Annovis Bio Inc options imply 5.8% move in share price post-earnings
Premium
The Fly
Annovis Bio Inc options imply 5.8% move in share price post-earnings
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Annovis Bio announces preclinical data on buntanetap with GLP-1 agonist
Premium
The Fly
Annovis Bio announces preclinical data on buntanetap with GLP-1 agonist
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100